Barinthus Biotherapeutics
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that guide T cells to address chronic infectious diseases and autoimmunity. The company is focused on advancing immunotherapies.
- Cancer immunotherapy
- Autoimmunity treatments
- Immunotherapies for chronic infectious diseases
Locations
Competitors
Immunocore Holdings plc is a pioneering biotechnology company that has developed the world's first approved T cell receptor (TCR) therapy.
Pathios Therapeutics is a clinical-stage oncology and immunology company focused on targeting the acid-sensing GPCR, GPR65, to revolutionise cancer treatment.
Company Details
Barinthus Biotherapeutics is operated by Barinthus Biotherapeutics Plc and is a Active company incorporated on 22 March 2021 with the registered office located in Altrincham, Greater Manchester. Barinthus Biotherapeutics Plc was registered 4 years ago.
Status
Active
Size
Micro
Directors
11
Age
4 years old
Employees
Unreported
Turnover
Unreported
Total Assets
£89.58M
Cash in Bank
Unreported
Total Liabilities
-£2.11M